Furthermore, the role of DLX6-AS1 has been reported as tumour-promoting in pancreatic cancer [96], non-small-cell lung cancer [97], and glioma [98] through inhibiting miR-181b, miR-144, and miR-197-5p, respectively, yet their association with the Notch1 signalling pathway has not been investigated in detail. Here, NOTCH1 is linked to non-small cell lung carcinoma.